Advances in Treating Chronic Disease| Book Publisher International

 Since ancient times, in the medical field, people have taken advantage of natural substances to cure diseases. Today, modern medicine is constantly developing, inheriting from the ancients to continue to conduct new research and produce effective treatment products for several diseases that are considered chronic today.

The compositions mentioned in the book have successfully treated a number of supposedly chronic diseases, such as cirrhosis and hepatocellular carcinoma caused by HBV and HCV infections; increased antibodies against COVID-19 in immunocompromised patients, infertility due to orchitis, the testicles are unable to produce spermatozoon, help the testicles complete five successive stages: (1) spermatogonia, (2) primary spermatocytes, (3) secondary spermatocytes, (4) spermatids, and (5) spermatozoon; protecting the fetus, and helping the fetus to develop to full term in a uterus with multiple fibroids. The selective compositions act on the patient's immune system, helping the body to resist harmful effects from the environment. Thanks to the natural substances: Flavonoids; Ascorbic Acid; Pyridoxal phosphate; Pregnenolone, they act as anti-inflammatory agents, enzymes that catalyze the body's chain reactions, as well as natural hormones. They have corrected chronic inflammatory disorders, tumors that grow out of control, causing a number of dangers to the patient's health. Research has shown that flavonoids and vitamins such as Ascorbic Acid, Pyridoxal phosphate, and Pregnenolone mentioned in this book have the necessary biological activity. They have a high impact potential, help the body to regulate, inactivate viruses, dissolve inflammatory tissue, prevent and destroy cancer cells at an early stage.

With practical evidence, the book will give readers an overview of the potential that needs to be discovered from nature to serve human life.

Author(s) Details:

Nguyen Thi Trieu,
Clinical Drug Research and Development Department under Saigon Biopharma Company, Vietnam.

Tran Minh Duc,
Clinical Drug Research and Development Department under Saigon Biopharma Company, Vietnam.

Tran Minh Cam Tu,
Clinical Drug Research and Development Department under Saigon Biopharma Company, Vietnam.

Please see the link here: https://stm.bookpi.org/ATCD/article/view/8972

Prevalence of Uterine Lesions Associated with Leiomyomas and Role of Endometrial Biopsy in Management: A Recent Study | Chapter 14 | Highlights on Medicine and Medical Science Vol. 14

 Background: The current study focuses on the link between symptomatic fibroids patients and illnesses such as endometriosis, adenomyosis, polyp, endometrial hyperplasia, and carcinoma. The goal was to see how useful endometrial biopsy was before surgery.

The goal of this study was to see if there was a link between symptomatic uterine fibroids and other uterine pathologies such as endometriosis, adenomyosis, endometrial hyperplasia, endometrial cancer, and endometrial/cervical polyps. To see how useful endometrial biopsy is before performing operational treatment like hysterectomy or myomectomy.

Methods: Women who underwent fibroid surgery or who had recently been diagnosed with fibroid were studied in an observational cohort study. There were a total of 150 women in attendance. To establish if there was a link between uterine pathology and fibroid, researchers looked at the histopathology reports of individuals who had already been operated on. Patients with leiomyoma had biopsy and reports analysed for the association, and ultrasonography findings were documented in prospective cases. To establish a relationship between a qualitative variable and a quantitative variable, a Chi-square test was used, with a p-value of 0.05 considered significant.

Out of 150 people, 24.6 percent had adenomyosis, 14% had endometrial hyperplasia (2 percent with atypia and 12 percent without), 8.6% had a cervical polyp, 5.33 percent had an endometrial polyp, 4% had endometriosis, and 42.7 percent had no relationship.

Conclusion: Leiomyomas are becoming more common in conjunction with uterine disorders, according to this study. Early diagnosis of endometrial illnesses based on clinical history and imaging helps identify high-risk individuals who require a biopsy to rule out malignancy, reducing the need for the normal D and C procedure that is performed in every case.

Author (S) Details

Minal J. Kumbhalwar
Department of Obstetrics and Gynaecology, Dr Babasaheb Ambedkar Memorial Central Railway Hospital, Byculla East, Mumbai, Maharashtra, India.

Anuradha Konda
BAMH Central Railway Hospital, Mumbai, India.

View Book :- https://stm.bookpi.org/HMMS-V14/article/view/2565